Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic algorithm for individualized controlled ovarian stimulation in assisted reproductive technology cycles.

Panminerva medica - 1 Mar 2019

Roque Matheus, Bianco Bianca, Christofolini Denise M, Barchi Cordts Emerson, Vilarino Fabia, Carvalho Waldemar, Valle Marcello, Sampaio Marcos, Geber Selmo, Esteves Sandro C, Parente Barbosa Caio

Abstract excerpt

Controlled ovarian stimulation (COS) is crucial for optimizing in-vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) success. Multiple factors influence the ovarian response to COS, making predictions about oocyte yields not so straightforward. As a result, the ovarian response may be poor or suboptimal, or even excessive, all of which have negative consequences for the affected patient. There is a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fertilization in Vitro
Share to Gonadotropins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infertility, Female

Share to Ovarian Follicle

Share to Ovulation Induction

Share to Reproductive Techniques, Assisted

Share to Sperm Injections, Intracytoplasmic

Source

Identifiers

PMID: 29916218
DOI: 10.23736/S0031-0808.18.03496-1

Genes

AMH

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic algorithm for individualized controlled ovarian stimulation in assisted reproductive technology cycles.PMID 29916218Read ↗

Pharmacogenetics of ovarian response.Semantic proximity Read ↗

Impact of gonadotropin genetic profile and ovarian reserve on controlled ovarian stimulation: data from prospective cohort of the GENACOS trialSemantic proximity Read ↗

Pharmacogenetics of controlled ovarian hyperstimulation.Semantic proximity Read ↗

Pharmacogenomics in IVF: A New Era in the Concept of Personalized Medicine.Semantic proximity Read ↗

Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis.Semantic proximity Read ↗

Phenotypic and pharmacogenetic aspects of ovulation induction in WHO II anovulatory women.Semantic proximity Read ↗

Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.Semantic proximity Read ↗

Genetic predictors of controlled ovarian hyperstimulation: where do we stand today?Semantic proximity Read ↗

Genome-wide analysis shows no genomic predictors of ovarian response to stimulation by exogenous FSH for IVF.Semantic proximity Read ↗

Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypesSemantic proximity Read ↗

AMHR2 c.-482A > G and serum basal FSH as predictors of ovarian response to stimulation.Semantic proximity Read ↗

Pharmacogenomic of LH and its receptor: are we ready for clinical practice?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.